Köhler, Jillian Clare
September 2009
Canadian Foreign Policy (CFP);2009, Vol. 15 Issue 3, p50
Academic Journal
The article discusses the amendment of patent law to improve global drug access by Canada. It states that Canada was the first country to amend its patent legislation to reestablish its place as a leader in international humanitarian policy. It also discusses the current focus of the Canadian government regarding pharmaceutical humanitarian. The effort to improve drug access globally has also reforms the intellectual property law.


Related Articles

  • Patents and access to essential drugs. Loff, Bebe // Transactions of the Royal Society of Tropical Medicine & Hygiene;Jan2003, Vol. 97 Issue 1, p6 

    This paper provides a brief overview of historical developments in patent law including its recent incorporation into world trade law. The impact of patents on access to essential drugs will be discussed. The relationship between intellectual property rights and the right to health will be...

  • Patent Challenges. J. W. // Pharmaceutical Executive;Jun2007, Vol. 27 Issue 6, p24 

    The article reports that Thailand Government and other third-world nations are challenging patents on critical therapies, a tactic that is stepping up into a serious international confrontation over intellectual property protection. Thailand has been trying to override drug patents on AIDS...

  • Replace pharmaceutical patents now. Grinols, Earl L; Henderson, James W. // PharmacoEconomics;2007, Vol. 25 Issue 5, p355 

    Pharmaceutical patents are anachronistic holdovers from an era in which modern economic understanding and tax tools were unavailable. Superior mechanisms lie somewhere between a first best pricing solution for the entire economy at one extreme and the current arrangements at the other. We...

  • Generic Pharmaceuticals: IP's Fiercest Litigation Arena. Andersen, Steven // Corporate Legal Times;Nov2003, Vol. 13 Issue 144, p28 

    Focuses on the complications in the generic drug application for patent rights by pharmaceutical companies in the U.S. Employment of strategy to extend the patent life of their products; Impact of the emergence of generic drugs on the pharmaceutical companies; Overview of the process of the...

  • Patients' groups voice patent fears.  // Telegraph (Calcutta, India);1/24/2015, p6 

    The article reports on the concerns of the health and patients' rights groups on the possible impact of the bilateral talks on the intellectual property rights that will allow drug companies to sell affordable generic medicines.

  • Report from: India. Nair, A. // Pharmaceutical Technology;Mar2009, Vol. 33 Issue 3, p18 

    The article discusses the condition of pharmaceutical industry's research and development (R&D) sector in India. According to the World Intellectual Property Organization (WIPO), compared with developed countries in terms of drug patent capitalizations, India is far behind due to the global...

  • Patent laws and the public good: IPR protection in Japan and... Baughn, C. Christopher; Bixby, Michael // Business Horizons;Jul/Aug97, Vol. 40 Issue 4, p59 

    Focuses on unprecedented growth in technological sophistication around the world that has led to an escalation in both the supply of and demand for intellectual property. Development of patent law in the United States and Japan; Comparing United States and Japanese patent systems; Cultural...

  • Barbed Wire in the research field. Lefort, Rene // UNESCO Courier;Nov2001, Vol. 54 Issue 11, p24 

    Talks about having the right balance between a scientist's private ownership of knowledge and distributing it to the public free of charge. Actions taken by scientists who feel their freedom is under threat by science publications; Issue regarding the scope of information and knowledge that...

  • TOWARD A DOCTRINE OF FAIR USE IN PATENT LAW. O'Rourke, Maureen A. // Columbia Law Review;Jun2000, Vol. 100 Issue 5, p1177 

    Focuses on issues concerning the role of fair use doctrine in patent laws to address market failures. Differences between the copyright and patent schemes; Identification of market failures that prevent socially efficient innovations in a high technology economy; Details on the pressures to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics